SRC Family Kinase Inhibition Through a New Pyrazolo[3,4-d]Pyrimidine Derivative as a Feasible Approach for Glioblastoma Treatment-Reference-Cited by-同舟云学术

SRC Family Kinase Inhibition Through a New Pyrazolo[3,4-d]Pyrimidine Derivative as a Feasible Approach for Glioblastoma Treatment

Published:2015-03-09 Issue:5 Volume:116 Page:856-863
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Ceccherini Elisa¹,Indovina Paola¹²,Zamperini Claudio³,Dreassi Elena³,Casini Nadia¹,Cutaia Ornella⁴,Forte Iris Maria⁵,Pentimalli Francesca⁵,Esposito Luca⁵,Polito Maria Sole¹²,Schenone Silvia⁶,Botta Maurizio²³,Giordano Antonio¹²⁵

Affiliation:

1. Department of Medicine, Surgery and Neuroscience; University of Siena and Istituto Toscano Tumori (ITT); Siena Italy

2. Sbarro Institute for Cancer Research and Molecular Medicine; Center for Biotechnology, College of Science and Technology, Temple University; Philadelphia Pennsylvania

3. Department of Biotechnology, Chemistry and Pharmacy; University of Siena; Siena Italy

4. Division of Medical Oncology and Immunotherapy, Department of Oncology, Istituto Toscano Tumori (ITT); University Hospital of Siena; Siena Italy

5. Oncology Research Center of Mercogliano (CROM); Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione Giovanni Pascale” IRCCS; Naples Italy

6. Pharmacy Department; University of Genoa; Genoa Italy

Funder

Sbarro Health Research Organization

Human Health Foundation

Commonwealth of Pennsylvania

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference37 articles.

1. Establishment and characterization of two cell lines derived from human glioblastoma multiforme;Bacciocchi;Anticancer Res,1992

2. Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation;Carraro;J Med Chem,2006